Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer.

MiRNAome colorectal cancer liver metastasis methylome transcriptome

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 29 12 2022
accepted: 20 03 2023
medline: 14 5 2023
pubmed: 14 5 2023
entrez: 14 5 2023
Statut: epublish

Résumé

Despite distant metastases being the critical factor affecting patients' survival, they remain poorly understood. Our study thus aimed to molecularly characterize colorectal cancer liver metastases (CRCLMs) and explore whether molecular profiles differ between Synchronous (SmCRC) and Metachronous (MmCRC) colorectal cancer. This characterization was performed by whole exome sequencing, whole transcriptome, whole methylome, and miRNAome. The most frequent somatic mutations were in

Identifiants

pubmed: 37182133
doi: 10.3389/fonc.2023.1133598
pmc: PMC10172672
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1133598

Informations de copyright

Copyright © 2023 Horak, Kubecek, Siskova, Honkova, Chvojkova, Krupova, Manethova, Vodenkova, García-Mulero, John, Cecka, Vodickova, Petera, Filip and Vymetalkova.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Oxid Med Cell Longev. 2022 Sep 9;2022:6570879
pubmed: 36120598
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nat Rev Clin Oncol. 2014 Aug;11(8):446-59
pubmed: 24889770
Front Oncol. 2021 Sep 02;11:702258
pubmed: 34540669
J Exp Clin Cancer Res. 2019 Jul 9;38(1):296
pubmed: 31288861
Ann Surg. 2006 Aug;244(2):254-9
pubmed: 16858188
Surg Oncol. 2018 Jun;27(2):280-288
pubmed: 29937183
Biochemistry. 1999 Sep 28;38(39):12943-9
pubmed: 10504266
Eur J Surg Oncol. 2012 Jan;38(1):16-24
pubmed: 22079259
Source Code Biol Med. 2016 Dec 15;11:13
pubmed: 27999612
Nat Rev Cancer. 2004 Feb;4(2):106-17
pubmed: 14732865
Signal Transduct Target Ther. 2022 Mar 4;7(1):70
pubmed: 35246503
Nat Commun. 2015 Apr 15;6:6879
pubmed: 25872451
Int J Mol Sci. 2020 Jul 24;21(15):
pubmed: 32722130
Br J Cancer. 2010 Jul 13;103(2):159-64
pubmed: 20551951
Science. 2017 Jul 07;357(6346):55-60
pubmed: 28684519
Mol Aspects Med. 2019 Oct;69:48-61
pubmed: 31365882
Cancers (Basel). 2020 Jun 09;12(6):
pubmed: 32527011
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Curr Oncol. 2021 May 18;28(3):1899-1908
pubmed: 34069871
Br J Surg. 2012 Apr;99(4):477-86
pubmed: 22261895
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
BMC Cancer. 2018 Jan 15;18(1):78
pubmed: 29334918
Crit Rev Oncog. 2013;18(1-2):43-73
pubmed: 23237552
Nucleic Acids Res. 2012 Sep 1;40(17):8484-98
pubmed: 22730302
J Surg Oncol. 2016 Dec;114(7):895-899
pubmed: 27696432
BMC Gastroenterol. 2012 Mar 23;12:24
pubmed: 22443372
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
J Med Genet. 2004 Aug;41(8):601-8
pubmed: 15286155
Front Pharmacol. 2023 Jan 24;14:1130562
pubmed: 36762108
Nat Commun. 2016 Aug 16;7:12436
pubmed: 27526785
World J Surg Oncol. 2019 Dec 26;17(1):228
pubmed: 31878952
Cells. 2018 Nov 21;7(11):
pubmed: 30469340
Hepatology. 2013 Jun;57(6):2346-57
pubmed: 23359206
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10535-10541
pubmed: 33155209
Sci Rep. 2021 Apr 14;11(1):8154
pubmed: 33854094
Oncogene. 2016 May;35(21):2777-88
pubmed: 26387546
Eur J Med Res. 2022 Jul 25;27(1):130
pubmed: 35879739
J Clin Invest. 2011 Nov;121(11):4526-36
pubmed: 21985787
Curr Opin Struct Biol. 2001 Dec;11(6):703-15
pubmed: 11751052
Curr Opin Cell Biol. 2018 Jun;52:30-42
pubmed: 29414591
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
BMC Bioinformatics. 2015 Jul 10;16:217
pubmed: 26156501
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
NAR Genom Bioinform. 2021 Jul 21;3(3):lqab068
pubmed: 34308351
World J Gastroenterol. 2011 Sep 28;17(36):4067-75
pubmed: 22039320
Mol Cancer. 2018 Aug 23;17(1):129
pubmed: 30139382
Cancers (Basel). 2020 Nov 03;12(11):
pubmed: 33152998
Sci Rep. 2022 Feb 16;12(1):2570
pubmed: 35173208
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Curr Colorectal Cancer Rep. 2017 Apr;13(2):101-110
pubmed: 28413363
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
J Biol Chem. 2002 Aug 2;277(31):27716-24
pubmed: 12016225
Nat Commun. 2017 Jan 25;8:14093
pubmed: 28120820
Ann Oncol. 2012 Oct;23(10):2619-2626
pubmed: 22431703
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Int J Mol Sci. 2022 Jan 31;23(3):
pubmed: 35163587
Bioinformatics. 2017 Aug 01;33(15):2381-2383
pubmed: 28369316
Oncoimmunology. 2018 Jul 30;7(10):e1490854
pubmed: 30386679
Biochim Biophys Acta. 2014 Nov;1843(11):2784-2795
pubmed: 25116306
Cancer. 1977 Oct;40(4 Suppl):1786-92
pubmed: 332330
J Pathol. 2001 Oct;195(3):336-42
pubmed: 11673831
Curr Probl Surg. 2018 Sep;55(9):330-379
pubmed: 30526930
Sci Rep. 2020 Sep 3;10(1):14591
pubmed: 32884102
Genes Dis. 2022 Feb 03;10(1):187-198
pubmed: 37013033
Clin Transl Oncol. 2020 Aug;22(8):1399-1406
pubmed: 31916018
Genom Data. 2016 May 26;9:22-4
pubmed: 27330998
Nat Commun. 2013;4:2612
pubmed: 24113773
Mol Biosyst. 2016 Feb;12(2):477-9
pubmed: 26661513
PLoS One. 2013 Sep 04;8(9):e74599
pubmed: 24023955
J Clin Oncol. 2007 Mar 1;25(7):773-80
pubmed: 17327601
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4246-4254
pubmed: 32373960
Front Mol Biosci. 2022 Jan 21;8:792779
pubmed: 35127817
Int J Colorectal Dis. 2011 Aug;26(8):967-81
pubmed: 21584664
Clin Cancer Res. 2013 Jul 15;19(14):3925-35
pubmed: 23729363
Ann Surg. 2014 Apr;259(4):735-43
pubmed: 23982750

Auteurs

Josef Horak (J)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Department of Medical Genetics, Third Faculty of Medicine, Charles University, Prague, Czechia.

Ondrej Kubecek (O)

Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Hradec Kralove, Czechia.

Anna Siskova (A)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czechia.

Katerina Honkova (K)

Department of Genetic Toxicology and Epigenetics, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.

Irena Chvojkova (I)

Department of Genetic Toxicology and Epigenetics, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.

Marketa Krupova (M)

The Fingerland Department of Pathology, University Hospital in Hradec Kralove, Hradec Kralove, Czechia.

Monika Manethova (M)

The Fingerland Department of Pathology, University Hospital in Hradec Kralove, Hradec Kralove, Czechia.

Sona Vodenkova (S)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.

Sandra García-Mulero (S)

Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO)-Oncobell Programme, Bellvitge Biomedical Research Institute Oncobell Programme, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), Oncobell Programme, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.

Stanislav John (S)

Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Hradec Kralove, Czechia.

Filip Cecka (F)

Department of Surgery, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Hradec Kralove, Czechia.

Ludmila Vodickova (L)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czechia.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.

Jiri Petera (J)

Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Hradec Kralove, Czechia.

Stanislav Filip (S)

Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University, Hradec Kralove, Czechia.

Veronika Vymetalkova (V)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czechia.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.

Classifications MeSH